Abstract
A stochastic version of the deterministic model for meningitis epidemic by Yaga and Saporu (2024) is developed. The stochastic mean system of equations for possible state of an individual in the model and the extinction probabilities for carrier and infective are derived. Comparison of the system of stochastic mean equations and its deterministic analogue of profiles for the various compartments and the case-carrier trajectories show similar pattern with a time shift difference. This indicates that there must be caution in using the deterministic analogue as an approximating system of the stochastic mean equations for inferential purpose. Simulation studies of the comparison of the compartmental profiles for the general case; model I, with the assumption that a proportion (φ ≠ 0), of the infected susceptible can move directly to the infective stage and that of the special case, model II, when φ = 0 is examined for various values of ϵ(odds in favour of a carrier transmitting infection) ≤ 2. It is only when ϵ = 2 that model II can approximate model I in all compartments except that of the carrier. Transmission rate, β, loss of carriership rate, σ and ϵ are identified as the most sensitive parameters of the extinction probabilities. Threshold results derived for carrier and infective extinction probabilities are distinct but bear some relation, transmission rate required for carrier extinction is square of that for infective. It is concluded that carriership play a more prominent role in the transmission of meningitis epidemic and efforts aimed at control should be targeted at reducing the transmission rate and increasing the loss of carriership.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
e-mail: saporuf{at}gmail.com
Data Availability
No Data used